These results demonstrated that DNMT1 and DNMT3B contribute to the hypermethylation of ALDH1A2, suggesting that they negatively regulate ALDH1A2 expression in ovarian cancer. This evidence concerns the gene ALDH1A2 and ovarian cancer.